Related by context. All words. (Click for frequent words.) 58 Hybridon 58 successfully commercialize Iluvien 57 orBec 56 ONCONASE R 56 Gastrotech 56 RIGScan CR 55 BioMarck 55 Glybera R 55 OvaRex R 54 Peptimmune 54 Tolerx 54 Elixir Pharmaceuticals 54 eprodisate Fibrillex TM 54 TransVax tm 54 MEND CABG II 54 Genz # 54 Alnara 54 Surfaxin LS 54 PLK1 SNALP 53 Poniard 53 MGCD# clinical trials 53 DPX Survivac 53 Neurobiological Technologies 52 Dr. Gulfo 52 Numoda 52 Poniard Pharmaceuticals 52 SNS# T 52 Trastuzumab DM1 52 Neose 52 Inflazyme 52 Dr. Scangos 52 Phase 2b RESTORE CLI 51 CIP TRAMADOL ER 51 ANTEGREN 51 EntreMed 51 Adherex 51 CardioVascular BioTherapeutics 51 tezampanel NGX# 51 SCOLR Pharma 51 Advanced Magnetics 51 Sigma Tau Pharmaceuticals 51 peginesatide 51 BLA filing 51 Arno Therapeutics 50 iii GTx 50 Corautus 50 Zonagen 50 sNDA submission 50 Bicifadine 50 SILENOR 50 dacetuzumab 50 Sanctura XR 50 Isotechnika Pharma 50 ARYx 50 postapproval 50 orBec R oral beclomethasone 50 ENZON 50 RenaMed 49 OraTest R 49 Alseres 49 Orathecin 49 AMPAKINE CX# 49 Celator 49 VALOR trial 49 Alfacell 49 PEG PAL 49 Neurocrine 49 sNDAs 49 Zemiva TM 49 Targanta 49 MacroChem 49 BLSI 49 PIX# [002] 49 pivotal bioequivalence 49 Lauren Silvernail 49 APTIMA HPV assay 49 NovaDel 49 Opexa 49 EndoBiologics 49 Neuraltus 49 OROS R Hydromorphone 49 BiDil XR 48 Genelabs 48 Prostate AdenoCarcinoma Treatment 48 IND submission 48 XTLbio 48 CoGenesys 48 EMPOWER TM 48 LigoCyte 48 Shire HGT 48 Allovectin 7 r 48 Dicerna 48 BioDelivery Sciences 48 ASONEP 48 Somaxon 48 DOR BioPharma 48 MDUFMA 48 ActivBiotics 48 ViRexx 48 biostatistical analysis 48 cadence regulatory approvals 48 LibiGel NDA 48 Neurocrine Biosciences 48 PIX# trial 48 Soligenix 48 PRECISE Trial 48 AIMM trial 48 Molecular Insight 48 rALLy trial 48 OTCBB DORB 48 AltaRex 47 pafuramidine 47 Ortho McNeil Janssen 47 Tovaxin 47 Furiex Pharmaceuticals 47 Intermezzo ® NDA 47 Proteostasis 47 Voraxaze 47 ADVENTRX 47 denosumab oncology 47 MIGENIX 47 Intellipharmaceutics 47 XP# XP# 47 Repros Therapeutics 47 CorMedix 47 Exelixis 47 ARIAD 47 SILENOR ™ 47 Myrexis 47 preclinical pharmacokinetic 47 Urocidin TM 47 Alkermes 47 synDNA TM 47 Alimera 46 eliglustat tartrate 46 PATH MVI 46 Bionutrics 46 Indevus Pharmaceuticals Inc. 46 alemtuzumab MS 46 TrialMaster TM 46 Furiex 46 Antigenics 46 Cempra 46 Viprinex 46 TOPIGEN 46 eTag assays 46 casopitant 46 ProUroScan prostate imaging 46 ENRICH trial 46 TASKi3 46 Depomed 46 Inhibitex 46 AMEX ONI 46 Neuradiab 46 Aspreva 46 Immunosyn 46 ICH guidelines 46 NeoLipid drug 45 Tranzyme 45 biogeneric drugs 45 Euthymics 45 CRHI 45 romidepsin 45 InSite Vision 45 Zensana TM 45 NEOPHARM 45 Hollis Eden 45 Biovest 45 iii Cubist 45 Advaxis Incorporated OTCBB ADXS 45 OVA1 TM 45 Corcept 45 Idenix 45 Ironwood Pharmaceuticals Inc. 45 vitro dissolution 45 Qualified Therapeutic Discovery 45 Celldex 45 J. Schaber PhD 45 generic biologic 45 VioQuest Pharmaceuticals 45 Tradeshow Products 45 Active Biotech 45 Enzon 45 andmanagement 45 Allos 45 XenoPort dependence 45 OXiGENE 44 BT VACC TM 44 Silenor NDA 44 Onalta 44 Biological License Application 44 lorcaserin NDA 44 PXD# 44 Amoxicillin PULSYS Phase III 44 Novelos 44 Indevus 44 BESST 44 EPIX Pharmaceuticals Inc. 44 Orthopedic Advisory Panel 44 antibiotic telavancin 44 ACADIA 44 involverisks 44 cGMPs 44 Simulations Plus 44 Haemacure 44 Keennon 44 Critical Outcome Technologies 44 Combating Counterfeit Drugs 44 ArQule 44 Biologics Licensing 44 Arisaph 43 Bioject 43 BiovaxID ® 43 SEQUENOM 43 Marketing Authorisation Application MAA 43 Contrave NDA 43 NDA BLA 43 Steve H. Kanzer 43 Palatin 43 CMC ICOS 43 QbD 43 Cellceutix actual 43 Ligand 43 Repros 43 Lipid Polymer Micelle LPM 43 PD2i CA 43 IntraBiotics 43 PRIMO CABG 43 ADMETRx 43 PDUFA date 43 Cubist Pharmaceuticals Inc. 43 hydrophobic docetaxel prodrug nanoparticle 43 CLIRS trial 42 Tarek Sherif CEO 42 Mr. Karbe 42 IFRS changeover 42 eCTD format 42 OHRP 42 BioTransplant 42 DOR BioPharma Inc. 42 MAQC 42 upon Trevali metallurgical 42 ATIR ™ 42 Titan Pharmaceuticals 42 bioengineered vaccines 42 Santhera 42 Affitech 42 bioresearch monitoring 42 indications contraindications 42 involve risksand uncertainties 42 AtheroGenics 42 Tekmira 42 biomarker validation 42 Flamel 42 Biotie 42 postmarket safety 42 Dyax 42 Biologic License Application 42 Biogen 42 Matritech 42 reflect Ronn Motors 42 nonclinical studies 42 Chemaphor 42 punctal plug 42 LeadDiscovery 42 alogliptin NDA 41 file INDs 41 Akorn 41 Prochymal Chondrogen 41 ARYx Therapeutics 41 CDER 41 xxxi adverse tax 41 CardioTech 41 InPath TM System 41 Selexis 41 reflect Ronn Motor 41 CombinatoRx 41 POZEN 41 SciClone 41 Medistem 41 Genta 41 Exelbine NDA 41 Microbia 41 silico modeling 41 GeneThera 41 Metabasis 41 NitroMed 41 Transgene therapeutic 41 ImmunoGen 41 #KSB 41 Synthon 41 PD2i ® algorithm 41 CPEX Pharmaceuticals 41 InSight Publisher 41 Anchen 41 Theravance 41 Cardiome 41 telavancin NDA 41 risksassociated 41 Toxin Alert Inc. 41 NDO Surgical 41 regardingthe 41 offuture 40 Akaza Research 40 Orosi Mill project 40 liposome formulations 40 GPC Biotech 40 SA Asgi SA 40 Pharma Payor benefit 40 Delcath 40 AVANT Immunotherapeutics Inc. 40 ViroPharma 40 Sandstorm Metals 40 biostatistical 40 Complete Response 40 Oncolytics Biotech Inc. 40 CuraGen 40 TSX VENTURE URO 40 DCAA audit 40 AURI 40 collaborator Genentech 40 arenot limited 40 factors APPY 40 ICH GCP guidelines 40 Senesco 40 condensate stripping 40 InfoStrength SES 40 Gene Logic 40 please visit www.comstockhomebuilding.com 40 biomarker discovery validation 40 genotoxicity studies 40 See www.claymore.com CEF 40 antiviral stockpiling 40 Standards CFATS 40 CLX Investments 40 Axcan 40 postmarketing surveillance 40 CDISC standards 40 TriLink BioTechnologies 39 Curis 39 Avigen 39 AVANT 39 PDUFA 39 Virtify 39 clinical endpoints 39 Achillion 39 Paragraph IV Notice 39 Neurodex TM 39 APPROVe trial 39 BioInvent 39 Act PDUFA 39 AOT ™ 39 CAUTIONARY STATEMENT Estimates 39 mutually satisfactory definitive 39 BurnsAdler 39 IVIVC 39 CTBG 39 Ceragenin ™ technology 39 EpiCept 39 CBER 39 Advancis 39 Clintrace 39 BioClinica Optimizer 39 infant formula contaminant 39 postmarketing studies 39 secondary efficacy endpoints 39 NeoPharm 39 eCTD submission 39 AndeanGold website 39 QMed 39 · Oversee 39 MacuCLEAR 38 Listings Qualification Panel 38 · Demonstrated 38 Archimedes Model 38 Vancocin 38 Geodex Minerals 38 Inclusionary housing 38 Qualyst 38 precommercial 38 · Coordinate 38 GELV gasification technology 38 Jinan Fertilizer 38 reprioritization 38 Unifill syringe 38 Sigma Tau 38 JIMO mission 38 Senomyx 38 NASDAQ Hearings Panel 38 vitro molecular diagnostic 38 Urigen URG# 38 Lamfalussy process 38 REMS 38 Purifine enzyme 38 GAAP Taxonomies 38 safer smallpox vaccines 38 inferential statistics 38 Cofactor 38 LCP adapts 38 gene annotation 38 Earned Value 38 Woltosz 38 optimal dosing 37 Fincom 37 CWMP 37 Arbortext IsoDraw 37 Cytogen dependence 37 Prescription Drug User Fee 37 DOR 37 TACIR 37 Nuvo Research 37 MMRC clinical trials 37 MAVDT 37 CDASH 37 securityholder approvals 37 reapproval 37 OTCBB RDIAF announces 37 PV module efficiencies 37 dioxin reassessment 37 Expect flyspeck scrutiny 37 Thallion 37 BioTech Medics 37 Calais LNG 37 surrogate endpoints 37 Transfac Capital 37 CAUTIONARY STATEMENT Statements 37 risksand uncertainties 37 NDAs 37 ratemaking principles 36 website www.bancroftfund.com 36 reflect Medicago 36 Primavera P6 Enterprise 36 theperformance 36 DMEPOS supplier 36 Form 8K #K 36 scoping prefeasibility 36 without limitation Terremark 36 McCain Opposes scheduling 36 Ambrilia 36 Schematic Design 36 FACT CHECK Stimulus 36 DOE USEC 36 CEP NEWS obtains 36 efficacy endpoints 36 Combined License Application 36 Questcor 36 HEVs PHEVs 36 END FOOTNOTE 36 measurable quantifiable 36 Consolidated Tomoka 36 Viability Plan 36 eSubmissions 36 toupdate 36 metallurgical geotechnical 36 disease progression TTP 36 siting permitting 36 www.dea.com 36 Anpath Group 36 Marc Richer LaFleche 36 timelines communicated 36 EGTT 36 MultiCell bases 36 eMDR 36 biosimilar applicant 36 MBLC 36 Kouilou Potash 36 IDED 35 IFRD1 35 ECG Warehouse 35 Taxware 35 DECD 35 OMIG 35 quantifications 35 Master Commutation Release 35 cethromycin NDA 35 theseforward looking 35 NJTPA 35 PDEIS 35 SEA Consultants 35 Zengen 35 Management EPCM 35 CIGSolar ™ 35 Stephanie Kwisnek spokeswoman 35 creditworthy shippers 35 MedAssurant 35 Generic Environmental Impact 35 Interpretative Communication 35 Atheros Quarterly Report 35 Unimpressed environmentalists called 35 Actively participates 35 Whether waivable 35 nonbinding blueprints 35 EDC 35 ETAAC 35 ARMOUR Residential REIT 35 DFMA 35 CPEX Pharmaceuticals Inc. 35 PlanGraphics 35 Updated Feasibility Study 35 Rosario Palmieri vice 34 AtheroNova filings 34 ourability 34 Vanasse Hangen Brustlin 34 iTechnology Forms Accelerator 34 subclassified based 34 etrials 34 Berkeley HeartLab 34 drilling recompletions 34 Corrective Action Order 34 PCI Express specification 34 Teradata DCM 34 metocean 34 Spike Jonze cinematic 34 Sturgeon Upgrader 34 PayChest 34 Recreational Trails Program 34 Vindicator LWS 34 NSDS III 34 traditional combinations CombinatoRx 34 virtual colonoscopy practitioner 34 Nasdaq Listing Qualification 34 Chairman Jonathan Rouis 34 Lycopodium Engineering 34 Toroparu Project 34 NOPR 34 ROVNER Well 34 MBTOC 34 GZA GeoEnvironmental 34 Product Profiles 34 ClearNova ThinkCAP offers 34 Biofuels Directive 34 concerning VAALCO 34 STATA 34 exome capture 34 QLT USA 34 otherfactors 34 SGEIS 33 Magma Talus IC 33 redefaults 33 coding debugging 33 VITL 33 constructability reviews 33 Mercator Geological Services 33 COAH regulations 33 DEDO 33 draft Supplemental Generic 33 underlying sulfide mineralization 33 ICMJE 33 bswift 33 NKorean nuke 33 Iacaponi 33 USDE 33 subjectto 33 SERONO 33 workplans 33 Inovio electroporation technology 33 YMPO 33 Gary Sasse 33 MHPAEA 33 GLASS ART Trial 33 Penalty Guidelines 33 prespecified criteria 33 predefined criteria 33 COMFORCE 33 Heska filings 33 Odessa Brody Plock Gdansk 33 PREE ™ product 33 nonfederal entities 33 RIEDC 33 Tumipampa 33 Oral Solid Dosage 33 Environment Impact Statement 33 Insulet inability 33 Lebowa transaction 33 QHSR 33 USDOC 33 outyears 33 outyear 32 Richard Pazdur director 32 Sensitivity analyzes 32 Offering Circulars 32 Stavneak 32 Prashanth Rajendran Pilgrim 32 companiesâ € ™ 32 may contact mchamplin@infocomm.org 32 Antares Pharma leverages 32 eCTD submissions 32 Norwalk Redevelopment Agency 32 Primavera P6 32 reauthorize NCLB 32 Irdeto CAS 3 32 RIPEC 32 Directive #.# 32 otherrisks 32 DMME 32 timelines 32 #QSB 32 Lori Severino 32 MDPH 32 FloTHERM IC 32 evaulate 32 Schedule UTP 32 Check http:/www.juneausoccer.com 32 PD VAL 32 Nortel remedial 32 assigning probabilities 32 TeleWRITER 32 Donna Ronayne 32 SIGA 32 CSDL 32 Belleterre Mine 32 Trofile 32 ODOD 32 explanatory memoranda 32 Natural Gas NJNG 32 GISCI 32 Utility MACT 32 Ferraro Law Firm 32 NFM celebrated 32 TSX VENTURE DOR 32 Demandware continually 32 ReBuilder Medical Technologies 31 Oracle BPEL 31 Work SOW 31 Thad Ide vice 31 ARRA Meaningful Use 31 CCIDA 31 Tarkiewicz 31 McDermott Wuchuan 31 intersessional meetings 31 DSTS G 31 TheAlliance 31 Buchans Minerals 31 Systemes Geostat International 31 SRPEDD 31 SDEIS 31 SBRC 31 purely conjectural 31 Listing Qualifications Panel 31 FMD vaccines 31 TSX VENTURE SMZ 31 ADH 31 vCloud API 31 Senate Appropriations Committees 31 CVTech 31 Value Enhancement Plan 31 USEB Chapter 31 La.Code Crim.P. art 31 Martecchini 31 Timescales 31 Garnaut Review 31 shorter timeframes 31 mutually exclusive strands 31 ADSI ability 31 BPEL specification 31 HRAdvance 31 TSX VENTURE ROX 31 SCEDC 31 feasibilty study 31 Meaningful Use criteria 31 Rev. Rul 31 GM BRNC 31 visit www.ashrae.org 31 Timelines 31 supplemental EIR 31 liberally construing 31 poly ADP ribose 31 JCIDA 31 OTI Annual Report 31 Oshlo 31 Philippe Brideau 31 Connarton 31 Guaranteed Maximum 31 measurable attainable 31 conflicting inferences 31 empirically verifiable 31 NJBPU 31 oBIX 31 Liquid Engines 31 Mike Magrum P.Eng 31 Kim Haberlin 31 Product Profiles qualitatively 31 bi directional transformations 31 REET 31 Visit IRS.gov 30 Paul Concemi 30 DLDC 30 § #A [003] 30 Rob Skjonsberg 30 ConnPACE 30 HTA periodic 30 Alpine TLI Group 30 Halfmile 30 Mark Schuling 30 Springsted 30 overpromise 30 Energtek filings 30 PharmaNet 30 DevEX 30 Gamblers Anonymous Meetings 30 Medidata Rave 30 GlobiTech 30 ISPI 30 normalized FFO guidance 30 programmatic EIS 30 Mazin Shuaib 30 LGPO 30 Optimum GAT corn 30 Breakdown Structure 30 PBBI provides 30 COAH obligations 30 product roadmaps 30 Maquat 30 Company nanocrystalline materials 30 BMRTL 30 likelihoods 30 Scheduling Order 30 COGFA 30 Mareane 30 Odessa Brody Gdansk 30 ZyIMAGE IAP 30 GCF certification 30 BRPC 30 Supplemental Environmental Impact 30 balanced scorecards 30 monitorable targets 30 Abdul Mahdi al Ameedi 30 ARPS redemptions 30 Determination Letter 30 ECMAScript Edition 4 30 NextGov reports 30 NFTL 30 PPLM 30 La.Civ.Code art 30 Embed X 29 Rubicon Minerals Corporation 29 FORMCAP 29 Concemi 29 LTE MIMO 29 subchapter S corporation 29 GSK Cytokinetics 29 viabilities 29 Tax Clearance Certificate 29 Brustlin Inc. 29 USPTO 29 GPS IIIA satellites 29 Specifications pricing 29 buildability 29 IRRRA 29 correctly Rosoff 29 Bankable Feasibility Study BFS 29 differentiating PERSONAL ELEMENT 29 Gramercy Realty Loans 29 IDOA 29 OCABR 29 BC EAO 29 RW Beck 29 CSR #-#.# 29 PRM NGO 29 DRED 29 RTO RPO 29 Ameriwest 29 invariable trendline upward 29 SCEM 29 Robert Koczera 29 FISMA compliance 29 SEMCAN seeks 29 Parente Randolph 29 WS Notification 29 Erik Abell 29 assign probabilities 29 WirelessHD specification 29 Rita Garbitt 29 enacting tort reform 29 Establish 29 imple mentation 29 Indore SEZ 29 Roger Wess 29 Passendro 29 Gwadosky 29 BSA AML compliance 29 UNMIS mandate 29 CROWLEY Again 29 NHIN Direct 29 Strategic Redeployment 29 Glen Dhu Project 29 Mmamabula Energy Project 29 La. Code Civ 29 VEDO 29 Orion Ares 29 NBN Implementation 29 prioritizations 29 XSPA 29 compressed timeframes 29 IDIQ contracts 29 Environmental Impact Statements 29 Suncor Firebag 29 Paragon Source 29 DHMH 29 OPRHP 29 Textura CPM 29 Reps. Barry Finegold 29 decadal surveys 29 Mediabox PA 29 NMED 29 WEDCO 29 outcome Wytkind 29 NHPUC 28 Legally binding 28 GHG emission reduction 28 Lomurro 28 Chudwick 28 Tax Compare.com 28 VentriPoint Diagnostic System 28 Public Utilities DPU 28 Submittal 28 ProSchools 28 deep sub micron 28 PICMG specifications 28 chasers motivations 28 jurisdictional thresholds 28 DHCD 28 CRHC 28 MTPDP 28 La. RS #:# [003] 28 TPCN 28 EOEA 28 OFPP 28 Blue Marble Geographics 28 Next Generation Networks NGNs 28 MITSC 28 Cantex 28 IRP# 28 Mitsue Pipelines 28 Devens Reuse Plan 28 Territorial Ministers 28 baggage misconnections 28 USDA APHIS 28 productization 28 FDICIA 28 approvals 28 RISDP 28 workstreams 28 integrated circuits ASIC 28 MMSEA 28 Meaningful Use requirements 28 Dan Salomone 28 PABP 28 contemporaneous documentation 28 Orvidas 28 Iowa Core Curriculum 28 EIS Environmental Impact 28 representations warranties covenants 28 PlanCon 28 Plimsoll chart 28 STEB 28 BWSR 28 INV 28 solutionsthat 28 Chad Kolton spokesman 28 predesign 28 Antun Domic senior 28 Timeframes 28 SWRPA 28 JNNSM 28 MAPC 28 website www.nac tsx.com 28 orders ECOs 28 LMO FFPs 28 Zuraski 28 Rivergreen Bank 28 Firebag Stage 3 28 submittal 28 QMI SAI Global 28 MassDevelopment 28 Cairn Vedanta 28 please email features@mirror.co.uk 28 Selectman Derek Maksy 28 HTRG 28 Staff Determination Letter 28 AAER 28 DEY 27 DCED 27 CHAIRMAN CONNAUGHTON Well 27 Joe Martuccio 27 CRFs 27 Gushan 27 DES 27 Amy Kempe 27 Certified Valuations 27 DailyFX Calendar 27 LighthouseMD 27 Sabrix 27 recontracting 27 Equivio Relevance 27 SeniorsPlus 27 Alico Agri 27 Brenda Voet spokeswoman 27 exhibits hereto constitute 27 drastically shortens 27 prejudgment remedy 27 DEMHS 27 SMMP 27 fundable 27 Beltway HOT lanes 27 Copanion 27 NJDEP 27 Section #D 27 BOEMRE staffing 27 mitigative measures 27 DPHSS 27 PPD 27 IPAP 27 ULJ 27 NHXS 27 Brodinsky 27 Dennis DiPinto 27 Dianor Resources Inc. 27 Sisitsky 27 '# +2' 27 tapeout schedules 27 guidances 27 ideal biocide 27 BEE codes 27 ARRA 27 Rob Sarro 27 S#D Publishing Suite 27 complexities inherent 27 NCLB reauthorization 27 Boggs Lightfoot 27 EHSMS 27 ECFSA 27 Balukonis 27 MACT standards 27 NYSDOH 27 RFI RFP 27 PHP IDE 27 Mortgagee Letter 27 fl exibility 27 Jennifer Nassour 27 Le Hegaret 27 MRPC 27 § #.#.# [002] 27 CVEC 27 stope preparation 27 · Ability 27 Norman Vacha 27 Lengthier 27 Linebarger Goggan 27 Gritziotis 27 reportability 27 DIRECTOR ORSZAG 27 results QoR 27 measurable outcomes 27 CZMP 27 CHAPA 27 OHCA 27 PQA Plus certification 27 permittable 27 projections 27 Bratcher Haas 27 NEORSD 27 RHCD 27 Kathy Burlison director 26 disallow deductions 26 JIL widget 26 feasiblity 26 Larobina 26 Treck TCP IP 26 FileLater 26 conceptional 26 reprioritizing 26 feasibilities 26 LCRA SAWS 26 PRB EIS 26 de confliction 26 OuterBay ADM Suite 26 Avitar 26 InforME 26 Listing Qualifications Staff 26 Oracle Primavera P6 26 Migration Accords 26 Schmiedicke 26 Entergy VY 26 apportioning delegates 26 Browse LNG 26 Ordering troop withdrawals 26 RIEMA 26 XpressCommerce 26 RIAC 26 #Gbps transceivers 26 Klatzkow 26 Augliere 26 legally demandable 26 MTFP 26 Deficiency Notice 26 Vision Appraisal Technology 26 Pepplitsch 26 JRT